Pharmacokinetic, pharmacological, and clinical profile of miglitol (SEIBULE®), a novel alpha-glucosidase inhibitor

Folia Pharmacologica Japonica

Volumn 127, Issue 3, 2006, Pages 223-232

  Kuboyama, Noboru ^a   Hayashi, Ichiro ^a   Yamaguchi, Tadashi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MIGLITOL; SEIBULE; UNCLASSIFIED DRUG; ALPHA GLUCOSIDASE; ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLUCOSAMINE; IMINOSUGAR;

PHARMACOKINETICS; PHARMACOLOGY; REVIEW; ANIMAL; ARTICLE; DOG; DRUG ANTAGONISM; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; RAT;

ALPHA-GLUCOSIDASES; ANIMALS; DIABETES MELLITUS, TYPE 2; DOGS; GLUCOSAMINE; HUMANS; HYPOGLYCEMIC AGENTS; IMINO PYRANOSES; RATS;

EID: 33747194728     PISSN: 00155691     EISSN: 13478397     Source Type: Journal    
DOI: 10.1254/fpj.127.223     Document Type: Review

References (38)

1. Rathmann W, et al. Diabetes Care. 2004;27(10):2568-2569.
2. Japanese source
3. Japanese source
4. UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837- 853.
5. Stratton IM, et al. BMJ. 2000;321(7258):405-412.
6. The DECODE study group. Lancet. 1999;354(9179):617-621.
7. Hanefeld M, et al. Diabetologia. 1996;39(12):1577-1583.
8. Tominaga M, et al. Diabetes Care. 1999;22(6):920-924.
9. Quagliaro L, et al. Diabetes. 2003;52(11):2795-2804.
10. Chiasson JL, et al. Lancet. 2002;359(9323):2072-2077.
11. Chiasson JL, et al. JAMA. 2003;290(4):486-494.
12. Hanefeld M, et al. Eur Heart J. 2004;25(1):10-16.
13. Ahr HJ, et al. Arzneimittelforschung. 1997;47(6):734-745.
14. Adolph EF. Science. 1949;109:579-585.
15. Japanese source
16. Japanese source
17. Japanese source
18. Japanese source
19. Japanese source
20. Japanese source
21. Samulitis BK, et al. Drugs Exp Clin Res. 1987;13(8):517-524.
22. Japanese source
23. Tormo MA, et al. Gen Pharmacol. 1998;30(1):125-129.
24. Madar Z, et al. J Basic Clin Physiol Pharmacol. 1993;4(1-2):69-81.
25. Madar Z. J Nutr. 1989;119(12):2023-2029.
26. Richardson M, et al. Atherosclerosis. 1998;138(1):135-146.
27. Japanese source
28. Japanese source
29. Fehmann HC. Fortschr Med Orig. 2001;119 Suppl 2:55-61.
30. de Luis Roman DA, et al. Rev Clin Esp. 2004;204:32-34.
31. Johnston PS, et al. J Clin Endocrinol Metab. 1998;83(5):1515-1522.
32. Butler AE, et al. Diabetes. 2003;52 (1):102-110.
33. Yoon KH, et al. J Clin Endocrinol Metab. 2003;88(5):2300-2308.
34. Sakuraba H, et al. Diabetologia. 2002;45(1):85-96.
35. Buchanan TA. Clin Ther. 2003;25 Suppl B:B32-46.
36. Carrascosa M, et al. Lancet. 1997;349(9053):698-699.
37. Japanese source
38. Japanese source